Max Robotics — Global Service Robot Directory + US Certification

About

Makoto Ohori is a leading urological surgeon whose research has fundamentally shaped the understanding and treatment of prostate cancer, particularly through the lens of surgical outcomes and robotic technology. His seminal work, the highly cited 1996 study “Risk Factors for Urinary Incontinence after Radical Prostatectomy” (534 citations), established critical preoperative predictors for this life-altering complication, providing a framework for patient counseling and surgical planning that remains influential decades later. Ohori’s subsequent research focuses on refining risk stratification for biochemical recurrence in high-risk prostate cancer and optimizing robot-assisted radical prostatectomy (RARP). He has systematically investigated how preoperative factors—such as prostate volume measured via transrectal ultrasonography—impact both surgical and oncological results. Notably, his work on the accessibility of surgical robot technology and its influence on patient behavior in Japan highlights the intersection of healthcare policy and clinical practice. As a pioneer in introducing robotic surgery to Japan, Ohori has been instrumental in documenting the nation’s early experience with the da Vinci system, contributing to the global adoption of minimally invasive techniques. His cumulative research, with papers spanning from the mid-1990s to the 2020s, demonstrates a sustained commitment to improving surgical precision and patient quality of life.